Prolonged response to 177 Lu-DOTATATE therapy of a bone marrow infiltration in a refractory thymic neuro endocrine tumor

This report highlights that PRRT could be an effective therapeutic option for advanced bone metastatic disease tNET, with the significant benefit of alleviation of bone pain and radiologic response, without severe or irreversible haematotoxicity.

Source: Investigational New Drugs - October 23, 2019 Category: Drugs & Pharmacology Source Type: research